A patient is complaining of a spinal headache. She had her procedure about 6 hours ago. What interventions are appropriate for the relief of spinal headache. (Select all that apply, one, some or all)

A. Sulfonylureasare oral hypoglycemic agents that stimulate pancreatic beta cells to release insulin. They are used exclusively in type 2 diabetes, as type 1 diabetes patients lack functional beta cells. A notable adverse effect of some first-generation sulfonylureas (e.g., chlorpropamide) is a disulfiram-like reactionwhen alcohol is consumed, causing flushing, nausea, vomiting, and hypotension. Examples include glipizide, glyburide, and glimepiride(second-generation sulfonylureas), which are safer but still can cause hypoglycemia.

B. Biguanides(e.g., metformin) do not stimulate insulin release; instead, they reduce hepatic glucose production and improve insulin sensitivity. They are used in type 2 diabetes but do not cause a disulfiram-like reaction.

C. Meglitinides(e.g., repaglinide, nateglinide) also stimulate insulin release, but they have a shorter duration of actionand do not typically cause a disulfiram-like reaction.

D. Thiazolidinediones(e.g., pioglitazone, rosiglitazone) increase insulin sensitivityin peripheral tissues rather than stimulating insulin release. They are used only for type 2 diabetes and do not cause a disulfiram-like reaction.

A. Nitrous oxide is a potent analgesic, providing excellent pain relief, which is why it is often used in combination with other anesthetics for balanced anesthesia. Its analgesic properties are especially beneficial for minor procedures or as an adjunct to reduce pain during surgery.

B. Nitrous oxide is not less likely to cause nausea and vomiting; in fact, it can sometimes increase postoperative nausea and vomiting (PONV). This is a known side effect, and antiemetics may be required.

C. Nitrous oxide has low anesthetic potency, so it is not used alone for surgical anesthesia. However, it is commonly used in combination with other inhalation anestheticsto reduce the required dose of more potent agents(dose-sparing effect). This helps minimize cardiovascular and respiratory depressioncaused by stronger anesthetics.

D. Nitrous oxide is less likely to precipitate malignant hyperthermia, a rare but life-threatening reaction triggered by some potent inhalation anesthetics like halothane, sevoflurane, or desflurane. Because of this, nitrous oxide is considered relatively safe in patients with susceptibility to malignant hyperthermia.

E. Nitrous oxide has low anesthetic potency, meaning it cannot produce surgical anesthesia by itself in most cases. Its MAC is very high (>100%), so it is almost always combined with more potent inhalational agents.